Showing results (61-70 of 138) with videos related to
Sort By:
Pageof 14
Basic & Clinical Pharmacology & Toxicology|March 25, 2016
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling MethodMarija Bosilkovska, Caroline Samer, Julien Déglon, et al.The New England Journal of Medicine|December 31, 2004
Codeine intoxication associated with ultrarapid CYP2D6 metabolismYvan Gasche, Youssef Daali, Marc Fathi, et al.Journal of Pharmaceutical and Biomedical Analysis|October 4, 2016
Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferasesStéphanie Romand, Dany Spaggiari, Niloufar Marsousi, et al.Basic & Clinical Pharmacology & Toxicology|September 26, 2012
Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic studyMarie Besson, Youssef Daali, Alessandra Di Lio, et al.Current Drug Metabolism|July 19, 2012
Transcriptional regulation of CYP2C19 and its role in altered enzyme activityChakradhara Rao S Uppugunduri, Youssef Daali, Jules Desmeules, et al.Drug Metabolism and Personalized Therapy|June 16, 2026
MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probeFaezeh Ahmadi, Hoda Lavasani, Mohammadhosein Keshvadi, et al.Journal of Environmental Management|July 7, 2015
Prioritization methodology for the monitoring of active pharmaceutical ingredients in hospital effluentsSilwan Daouk, Nathalie Chèvre, Nathalie Vernaz, et al.Clinical Therapeutics|November 14, 2015
Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case StudyMarija Bosilkovska, Kuntheavy Ing Lorenzini, Chakradhara Rao S Uppugunduri, et al.Clinical Pharmacology and Therapeutics|May 20, 2022
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure SimulationJean Terrier, Frédéric Gaspar, Monia Guidi, et al.Frontiers in Pain Research (Lausanne, Switzerland)|June 9, 2023
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocolFederica Bianchi, Sophie Pautex, James Wampfler, et al.Pageof 14